Vicarious Surgical (RBOT) ZACKS·2025-03-20 17:00Core Viewpoint - Vicarious Surgical Inc. (RBOT) has been upgraded to a Zacks Rank 2 (Buy), indicating a positive outlook based on rising earnings estimates, which significantly influence stock prices [1][3]. Earnings Estimates and Stock Price Movement - The Zacks rating system emphasizes the correlation between changes in earnings estimates and stock price movements, driven by institutional investors who adjust their valuations based on these estimates [4][6]. - An increase in earnings estimates typically leads to higher fair value for a stock, prompting institutional buying or selling, which in turn affects stock prices [4]. Company-Specific Insights - For Vicarious Surgical, the upgrade reflects an improvement in the company's underlying business, suggesting that investor sentiment will likely drive the stock price higher [5]. - The Zacks Consensus Estimate for the company has increased by 15.9% over the past three months, with an expected earnings per share of -$7.15 for the fiscal year ending December 2025, representing a year-over-year change of 33.5% [8]. Zacks Rating System Overview - The Zacks Rank system classifies stocks into five groups based on earnings estimates, with a proven track record of Zacks Rank 1 stocks generating an average annual return of +25% since 1988 [7]. - The upgrade to Zacks Rank 2 positions Vicarious Surgical in the top 20% of Zacks-covered stocks, indicating strong potential for market-beating returns in the near term [10].